Full-year 2024 sales of $9.8 billion, up 5%, or up 6% constant currency1 (cc) Full-year 2024 diluted EPS of $2.05, up 5% on a reported basis, or up 11% cc; core diluted EPS2 of $3.05 up 11% on a reported basis, or up 16% cc Generated record $2.1 billion of cash from operations in full-year … [Read more…]
LONDON & NEW YORK–(BUSINESS WIRE)–$CMPS #Biotech–Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will present at the TD Cowen 45th Annual Health Care Conference at 1:10 pm ET on March 3rd, 2025. A live audio webcast of the presentation will … [Read more…]
The fastest-growing senior living medication management solution in recent history has been embraced by clinical leaders, caregiving staff, and pharmacy partners. SAN FRANCISCO–(BUSINESS WIRE)–August Health is proud to share that August Health eMAR, its next-generation electronic medication administration record, is now available to senior living operators across the United States. As the first new solution … [Read more…]
SAN ANTONIO–(BUSINESS WIRE)–#BIAF—bioAffinity Technologies, Inc. (NASDAQ: BIAF and BIAFW) announced today it has entered into warrant exercise agreements with three existing accredited investors to exercise certain outstanding warrants to purchase an aggregate of 2,438,473 of the Company’s shares of common stock (the “Existing Warrants”). In consideration for the immediate exercise in full of the Existing … [Read more…]
PRINCETON, N.J.–(BUSINESS WIRE)–Bristol Myers Squibb (NYSE: BMY) today announced that the company will participate in two upcoming investor conferences in March 2025. The company will participate in a fireside chat at the TD Cowen 45th Annual Health Care Conference on March 4, 2025, at 2:30 p.m. ET. In addition, the company will take part in … [Read more…]
First-of-its-Kind European Pilot Study Shows Improvement in Mood, Energy, and Anxiety—Fueling Hope for a New Mental Health Treatment SAN MATEO, Calif.–(BUSINESS WIRE)–#Bipolar–Baszucki Group today announced a new pilot study on a ketogenic diet in bipolar disorder. “For the first time in years, I felt like my brain was finally running on the right fuel,” said … [Read more…]
New Laboratory Study Highlights Novel Approach to Disease Management Under Development MARTINEZ, Calif.–(BUSINESS WIRE)–A new laboratory study has provided insights into the potential therapeutic benefits of blood purification for patients with metastatic pancreatic ductal adenocarcinoma (PDAC), one of the deadliest forms of cancer. Researchers have demonstrated that ExThera Medical’s Seraph® 100 Microbind ® Affinity Blood … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Epilepsy Drugs Market Size and Share Analysis – Growth Trends and Forecast Report 2025-2033” report has been added to ResearchAndMarkets.com’s offering. The Epilepsy Drugs market is forecast to experience significant growth, with estimations projecting the market to reach US$ 11.85 billion by 2033, up from US$ 7.92 billion in 2024. Analysts attribute this … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Bispecific Antibody & Cancer Patent Landscape Analysis” report has been added to ResearchAndMarkets.com’s offering. The development of bispecific antibodies (bsAbs) in oncology is experiencing rapid growth, accompanied by significant clinical advancements. According to recent data, more than 85% of bsAbs in clinical trials are cancer treatments, with approximately 600 bsAbs currently in clinical … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “RFID in Healthcare – Global Strategic Business Report” has been added to ResearchAndMarkets.com’s offering. The global market for RFID in Healthcare was valued at US$6.9 Billion in 2024 and is projected to reach US$15.7 Billion by 2030, growing at a CAGR of 14.6% from 2024 to 2030. This comprehensive report provides an in-depth … [Read more…]
